Figure 6.1
Adjusted all-cause mortality (deaths per 1,000 patient-years) by treatment modality (a) overall, dialysis, and transplant, and (b) hemodialysis and peritoneal dialysis, for period-prevalent patients, 1996-2013
(a) Overall, dialysis, and transplant
Overall, dialysis, and transplant
(b) Hemodialysis and peritoneal dialysis
Hemodialysis and peritoneal dialysis
Data Source: Reference Tables H.2_adj , H4_adj, H.8_adj, H.9_adj, and H.10_adj; and special analyses, USRDS ESRD Database. Adjusted for age, sex, race, ethnicity, primary diagnosis and vintage. Ref: period prevalent ESRD patients, 2011. Abbreviations: HD, hemodialysis; PD, peritoneal dialysis.

Figure 6.2
Adjusted all-cause mortality (deaths per 1,000 patient-years) by treatment modality, cohort (year of ESRD onset), and number of years after start of dialysis among incident (a) hemodialysis patients and (b) peritoneal dialysis patients, 1996, 2001, 2006, and 2011
(a) Hemodialysis patients
Hemodialysis patients
(b) Peritoneal dialysis patients
Peritoneal dialysis patients
Data Source: Special analyses, USRDS ESRD Database. Adjusted for age, sex, race, and primary diagnosis. Ref: period prevalent ESRD patients, 2011. Abbreviation: ESRD, end-stage renal disease.

Figure 6.3
Adjusted mortality (deaths per 1000 patient-years) by treatment modality and number of months after treatment initiation among ESRD patients, 2012
Adjusted mortality (deaths per 1000 patient-years) by treatment modality and number of months after treatment initiation among ESRD patients, 2012
Data Source: Special analyses, USRDS ESRD Database. Adjusted (age, race, sex, ethnicity, and primary diagnosis) mortality among 2012 incident ESRD patients during the first year of therapy. Ref: incident ESRD patients, 2011. Abbreviations: ESRD, end-stage renal disease; HD, hemodialysis; PD, peritoneal.

Adjusted all-cause mortality (deaths per 1,000 patient-years) by patient age and race among ESRD patients, 2012

Unadjusted percentages of deaths due to cardiovascular disease (CVD), infection, other specified causes, and with missing data, by modality among ESRD patients, 2012

Treatment modality and incident cohort year (year of ESRD onset)
Age, sex, race, and primary cause of ESRD

Expected remaining lifetime (years) by age, sex, and treatment modality of prevalent dialysis patients, prevalent transplant patients, and the general U.S. population (2012), based on USRDS data and the National Vital Statistics Report (2013)

Adjusted mortality (deaths per 1,000 patient-years) by age, sex, treatment modality, and Medicare comorbidity among ESRD patients and people covered by Medicare in 2013, based on USRDS and CMS data, 2013

Adjusted mortality (deaths per 1,000 patient-years) by calendar year, treatment modality, and Medicare comorbidity among ESRD patients and comorbidity-specific Medicare populations aged 65 & older, 1996-2013